chartexchange

ATOS
Atossa Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:58:54 PM EST
1.79USD-5.526%(-0.11)44,435
After-hoursNov 18, 2026 4:00:30 PM EST
1.81USD+0.836%(+0.02)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Steven Quay
HQ
Seattle, WA, USA
Previous Close
$1.90
Beta
0.60
52-Week High
$14.85 2025-12-11
52-Week Low
$1.70 2026-06-25
SMA 50
$2.31
SMA 200
$3.53
Avg. Vol 10D
58,132
Avg. Vol 30D
81,572
Avg. Vol 90D
68,335
Relative Vol
0.54
9.83M
1.4400%
165
Feb 2, 2026 · 1-for-15 (reverse)
ATOS Profile

atossa therapeutics, inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the united states. the company's lead program is the development of endoxifen, an active metabolite of tamoxifen which is in phase ii studies to treat and prevent breast cancer. it is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and chimeric antigen receptor t-cell therapies, directly to the site of breast cancer. the company was formerly known as atossa genetics inc. and changed its name to atossa therapeutics, inc. in january 2020. atossa therapeutics, inc. was founded in 2009 and is headquartered in seattle, washington.

ATOS Performance
PeriodPriceDateChangeBeta
1W2.032026-11-11-11.33%-0.130
1M2.562026-10-19-29.69%-0.168
3M2.592026-08-18-30.50%-0.026
6M4.782026-05-18-62.34%-0.235
1Y11.852025-11-18-84.81%0.599
2Y19.202024-11-18-90.63%—
5Y34.352021-11-18-94.76%1.118
ATOS Stock Summary

Atossa Therapeutics, Inc. Common Stock (NASDAQ:ATOS) stock price today is $1.80, and today's volume is 44,435. ATOS is down 5.263% today. The 30 day average volume is 81,572. ATOS market cap is $17.96M with 9.98M shares outstanding.